Dia-Präsentation von Serono Austria GMBH EVIDENCE-Umstellungsstudie (22 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken) | ||||||||||||||||||
Abbildung 13: Schubrate Relapse rate providing possibly the most relevant statistical comparison – final interval pre-T and first interval post-T. Both groups improve (?regression over time, fewer contacts, full effect of Rx being seen etc.) but the difference is considerably greater for 30 to 44 than 44/44 and brings the Avonex patient rate to that of Rebif patient rate. |
Abbildung 13: Schubrate
Relapse rate providing possibly the most relevant statistical comparison – final interval pre-T and first interval post-T. Both groups improve (?regression over time, fewer contacts, full effect of Rx being seen etc.) but the difference is considerably greater for 30 to 44 than 44/44 and brings the Avonex patient rate to that of Rebif patient rate. |
